You searched for dna - Page 23 of 39

CRISPR Therapeutics, CRISPR-Cas9, genome editing, biotech

News and Trends 17 Oct 2022

CRISPR/Cas9: Challenges and outlook from an investor’s perspective

…greatest scientific advancements of the last 100 years. In 2012, Jennifer Doudna and Emanuelle Charpentier published a peer-reviewed paper discussing the use of CRISPR/Cas9 in gene editing. They probably didn’t…

October 17, 2022 - 6 minutesmins - By External Contributor

Best in Biotech 7 Mar 2024

6 biotech companies tackling antibiotic resistance

…focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates that block a new molecular target called DNA polymerase…

March 7, 2024 - 8 minutesmins - By Willow Shah-Neville

Covid 19 manufacturing vaccine therapies antibody

News and Trends 9 Dec 2020

The Manufacturing Challenge to Meet Covid-19 Vaccine Demands

…a pandemic has been challenging to say the least.” Touchlight DNA services, the contract manufacturing arm of UK biotech Touchlight Genetics, aims to support Covid-19 drug and vaccine manufacture by…

December 9, 2020 - 5 minutesmins - By Helen Albert

News and Trends 15 Feb 2022

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

…vaccine development include improving the manufacture, supply, and distribution of Covid-19 vaccines. Additionally, improving vaccine access in these regions could reduce the likelihood of dangerous variants emerging. DNA vaccines are…

February 15, 2022 - 7 minutesmins - By Jonathan Smith

Best in Biotech 15 Mar 2023

7 biotechs in Hungary you should know about

…protein CDC7 contributes to DNA replication in cells, however, its overexpression has been regarded as a marker in cancers like colorectal cancer. CDC7 inhibitors target the enzyme CDC7 kinase, which…

March 15, 2023 - 9 minutesmins - By Alex Dale

News and Trends 4 Oct 2021

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain

…in development include delivering DNA to tissues via electric currents, as developed by the Parisian firm Eyevensys, and transfection, a technology that relies on small DNA molecules called plasmids to…

October 4, 2021 - 5 minutesmins - By Victor Kotsev

In Depth 4 Nov 2020

The Return of Gene Therapy

…DNA sequences into patients’ cells for treating people with genetic disorders. However, they urged caution in the development of the technology, pointing out several key bottlenecks in scientific understanding that…

November 4, 2020 - 8 minutesmins - By Farhan Mitha

News and Trends 24 Feb 2017

What are the Current Challenges in the Booming Field of ADCs?

…the minor groove of DNA. The optimally snug fit makes Tesirine the most effective cross-linking agent that is thereby able to damage DNA and induce cell death. On the left,…

February 24, 2017 - 5 minutesmins - By Evelyn Warner

Best in Biotech 1 Oct 2024

Lithuania’s biotech: Six companies to put on your radar

…based in Vilnius, Lithuania, was set up to broaden the range of Cas proteins that can snip DNA. This could allow edits to be made in more sites in the…

October 1, 2024 - 6 minutesmins - By Jules Adam

ASCO 2024: advances in oncology clinical trials

In Depth 10 Jun 2024

ASCO 2024: The latest advances in oncology clinical trials

…based on early clinical data. Both the candidates designed to induce cell death by interrupting DNA replication, boosted antitumor activity in patients. Another ADC in the limelight was British multinational…

June 10, 2024 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 25 Apr 2024

8 of the most expensive drugs in biopharma: Unraveling the costliest medications

…DNA instructions to the liver, where factor IX proteins are then generated. These genetic instructions remain in the target cells but generally do not become a part of a person’s…

April 25, 2024 - 12 minutesmins - By Willow Shah-Neville

News and Trends 11 Mar 2019

Monthly Injection Proves as Good as Daily Pills Against HIV in Phase III

…company ViiV Healthcare in collaboration with Janssen, this monthly treatment is a combination of two drugs. One, called rilpirivine, blocks the protein that turns the virus’ genetic material into DNA….

March 11, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: dna

CRISPR/Cas9: Challenges and outlook from an investor’s perspective

6 biotech companies tackling antibiotic resistance

The Manufacturing Challenge to Meet Covid-19 Vaccine Demands

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

7 biotechs in Hungary you should know about

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain

The Return of Gene Therapy

What are the Current Challenges in the Booming Field of ADCs?

Lithuania’s biotech: Six companies to put on your radar

ASCO 2024: The latest advances in oncology clinical trials

8 of the most expensive drugs in biopharma: Unraveling the costliest medications

Monthly Injection Proves as Good as Daily Pills Against HIV in Phase III

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!